MetLife Investment Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,585
| Closed | -$97.4K | – | 3007 |
|
|
2023
Q1 | $97.4K | Hold |
15,585
| – | – | ﹤0.01% | 2564 |
|
|
2022
Q4 | $95.1K | Hold |
15,585
| – | – | ﹤0.01% | 2614 |
|
|
2022
Q3 | $186K | Hold |
15,585
| – | – | ﹤0.01% | 2345 |
|
|
2022
Q2 | $197K | Hold |
15,585
| – | – | ﹤0.01% | 2327 |
|
|
2022
Q1 | $175K | Buy |
15,585
+5,658
| +57% | +$63.7K | ﹤0.01% | 2434 |
|
|
2021
Q4 | $176K | Hold |
9,927
| – | – | ﹤0.01% | 2134 |
|
|
2021
Q3 | $229K | Buy |
+9,927
| New | +$229K | ﹤0.01% | 2006 |
|
|
2021
Q2 | – | Sell |
-6,421
| Closed | -$200K | – | 2502 |
|
|
2021
Q1 | $200K | Buy |
+6,421
| New | +$200K | ﹤0.01% | 2051 |
|